These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17225940)

  • 1. Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer.
    Rades D; Schulte R; Yekebas EF; Homann N; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Jan; 183(1):10-6. PubMed ID: 17225940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
    Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
    Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy.
    Rades D; Fehlauer F; Wroblesky J; Albers D; Schild SE; Schmidt R
    Oral Oncol; 2007 Jul; 43(6):535-43. PubMed ID: 17005437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.
    Ishikawa H; Sakurai H; Tamaki Y; Nonaka T; Yamakawa M; Saito Y; Kitamoto Y; Higuchi K; Hasegawa M; Nakano T
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1290-6. PubMed ID: 16872312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoetin-alpha during radiotherapy for stage III esophageal carcinoma.
    Rades D; Schild SE; Yekebas EF; Job H; Schwarz R; Rudat V
    Cancer; 2005 Jun; 103(11):2274-9. PubMed ID: 15852356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation.
    Rades D; Golke H; Schild SE; Kilic E
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):152-9. PubMed ID: 17967510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
    Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
    Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.
    Gunderson LL; Sargent DJ; Tepper JE; Wolmark N; O'Connell MJ; Begovic M; Allmer C; Colangelo L; Smalley SR; Haller DG; Martenson JA; Mayer RJ; Rich TA; Ajani JA; MacDonald JS; Willett CG; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1785-96. PubMed ID: 15067027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma.
    Fuchs S; Rödel C; Brunner T; Iro H; Niedobitek G; Sauer R; Grabenbauer GG
    Onkologie; 2003 Feb; 26(1):12-8. PubMed ID: 12624512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
    Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin.
    Rades D; Kuhn H; Schultze J; Homann N; Brandenburg B; Schulte R; Krull A; Schild SE; Dunst J
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1087-93. PubMed ID: 17892921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study.
    Rades D; Tribius S; Yekebas EF; Bahrehmand R; Wildfang I; Kilic E; Muellerleile U; Gross E; Schild SE; Alberti W
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):459-65. PubMed ID: 16584851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment proliferation and local control in bladder cancer after radiotherapy with or without concurrent chemotherapy.
    Weiss C; Rödel F; Ott O; Engehausen DG; Papadopoulos T; Sauer R; Rödel C
    Strahlenther Onkol; 2007 Oct; 183(10):552-6. PubMed ID: 17896086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
    Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
    Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy.
    Kelsey CR; Nelson JW; Willett CG; Chino JP; Clough RW; Bendell JC; Tyler DS; Hurwitz HI; Morse MA; Clary BM; Pappas TN; Czito BG
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1436-41. PubMed ID: 17689032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.